Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4858 | 1643 | 36.8 | 82% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
724 | 12071 | HEART FAILURE//NATRIURETIC PEPTIDES//B TYPE NATRIURETIC PEPTIDE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NESIRITIDE | Author keyword | 73 | 67% | 4% | 66 |
2 | ACUTE HEART FAILURE | Author keyword | 63 | 30% | 11% | 179 |
3 | CARDIORENAL SYNDROME | Author keyword | 62 | 46% | 6% | 100 |
4 | WORSENING RENAL FUNCTION | Author keyword | 61 | 78% | 2% | 40 |
5 | ACUTE DECOMPENSATED HEART FAILURE | Author keyword | 35 | 44% | 4% | 60 |
6 | CLIN MIL HOSP | Address | 21 | 71% | 1% | 17 |
7 | ACUTE HEART FAILURE SYNDROMES | Author keyword | 15 | 63% | 1% | 15 |
8 | ROLOFYLLINE | Author keyword | 10 | 73% | 0% | 8 |
9 | CARDIO RENAL SYNDROME | Author keyword | 9 | 36% | 1% | 20 |
10 | CARDIOVASC INNOVAT | Address | 9 | 18% | 3% | 43 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NESIRITIDE | 73 | 67% | 4% | 66 | Search NESIRITIDE | Search NESIRITIDE |
2 | ACUTE HEART FAILURE | 63 | 30% | 11% | 179 | Search ACUTE+HEART+FAILURE | Search ACUTE+HEART+FAILURE |
3 | CARDIORENAL SYNDROME | 62 | 46% | 6% | 100 | Search CARDIORENAL+SYNDROME | Search CARDIORENAL+SYNDROME |
4 | WORSENING RENAL FUNCTION | 61 | 78% | 2% | 40 | Search WORSENING+RENAL+FUNCTION | Search WORSENING+RENAL+FUNCTION |
5 | ACUTE DECOMPENSATED HEART FAILURE | 35 | 44% | 4% | 60 | Search ACUTE+DECOMPENSATED+HEART+FAILURE | Search ACUTE+DECOMPENSATED+HEART+FAILURE |
6 | ACUTE HEART FAILURE SYNDROMES | 15 | 63% | 1% | 15 | Search ACUTE+HEART+FAILURE+SYNDROMES | Search ACUTE+HEART+FAILURE+SYNDROMES |
7 | ROLOFYLLINE | 10 | 73% | 0% | 8 | Search ROLOFYLLINE | Search ROLOFYLLINE |
8 | CARDIO RENAL SYNDROME | 9 | 36% | 1% | 20 | Search CARDIO+RENAL+SYNDROME | Search CARDIO+RENAL+SYNDROME |
9 | DECOMPENSATED HEART FAILURE | 8 | 31% | 1% | 22 | Search DECOMPENSATED+HEART+FAILURE | Search DECOMPENSATED+HEART+FAILURE |
10 | DIURETIC RESISTANCE | 7 | 36% | 1% | 15 | Search DIURETIC+RESISTANCE | Search DIURETIC+RESISTANCE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | WORSENING RENAL FUNCTION | 220 | 68% | 12% | 195 |
2 | INTRAVENOUS NESIRITIDE | 114 | 61% | 7% | 122 |
3 | NATIONAL REGISTRY ADHERE | 80 | 59% | 6% | 91 |
4 | CARDIORENAL SYNDROME | 43 | 42% | 5% | 78 |
5 | EXTRACORPOREAL ULTRAFILTRATION | 42 | 74% | 2% | 31 |
6 | NESIRITIDE | 36 | 37% | 5% | 76 |
7 | HIGH DOSE FUROSEMIDE | 33 | 49% | 3% | 49 |
8 | E Z 3 2 AMINOETHOXYIMINOANDROSTANE 6 17 DIONE HYDROCHLORIDE | 31 | 92% | 1% | 12 |
9 | DIURETIC RESISTANCE | 22 | 62% | 1% | 23 |
10 | ROLOFYLLINE | 21 | 75% | 1% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Global Health and Economic Burden of Hospitalizations for Heart Failure Lessons Learned From Hospitalized Heart Failure Registries | 2014 | 33 | 74 | 36% |
The kidney in heart failure: an update | 2015 | 2 | 58 | 74% |
Diuretic response in acute heart failure -pathophysiology, evaluation, and therapy | 2015 | 3 | 83 | 41% |
Steps forward in regulatory pathways for acute and chronic heart failure | 2015 | 2 | 9 | 44% |
Acute Heart Failure Syndromes | 2009 | 162 | 135 | 50% |
The role of the kidney in heart failure | 2012 | 32 | 62 | 68% |
Rehospitalization for Heart Failure Problems and Perspectives | 2013 | 61 | 61 | 30% |
Cardiorenal Syndrome New Perspectives | 2010 | 116 | 65 | 38% |
The vulnerable phase after hospitalization for heart failure | 2015 | 2 | 70 | 30% |
Diuretics and Ultrafiltration in Acute Decompensated Heart Failure | 2012 | 24 | 63 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN MIL HOSP | 21 | 71% | 1.0% | 17 |
2 | CARDIOVASC INNOVAT | 9 | 18% | 2.6% | 43 |
3 | INT RENAL | 6 | 31% | 1.0% | 16 |
4 | USC CARDIOVASC MED | 6 | 100% | 0.2% | 4 |
5 | ASSOC NAZL MED CARDIOL | 5 | 60% | 0.4% | 6 |
6 | AHMANSON UCLA CARDIOMYOPATHY | 5 | 17% | 1.6% | 27 |
7 | MIL HOSP | 5 | 27% | 1.0% | 16 |
8 | MIDWEST HEART FDN | 5 | 55% | 0.4% | 6 |
9 | CLIN CARDIOL HEART FAILURE | 4 | 67% | 0.2% | 4 |
10 | COLORADO CARDIOVASC OUTCOMES CONSORTIUM | 4 | 67% | 0.2% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000163654 | EUROPEAN JOURNAL OF HEART FAILURE//JOURNAL OF CARDIOVASCULAR NURSING//JOURNAL OF CARDIAC FAILURE |
2 | 0.0000133790 | CARDIORENAL ANEMIA SYNDROME//CONGEST HEART FAILURE UNIT//PL CARDIOVASC SYST |
3 | 0.0000127303 | HEART FAILURE WITH PRESERVED EJECTION FRACTION//DIASTOLIC HEART FAILURE//PRESERVED EJECTION FRACTION |
4 | 0.0000102334 | LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER |
5 | 0.0000098508 | ANTIDIABETIC PHARMACOTHERAPY//CHAIR GERIATR SURG//HEART FAILURE INCOR |
6 | 0.0000084602 | INTRATHORACIC IMPEDANCE//REMOTE FOLLOW UP//REMOTE MONITORING |
7 | 0.0000082868 | TORASEMIDE//TORSEMIDE//FUROSEMIDE |
8 | 0.0000082240 | B TYPE NATRIURETIC PEPTIDE//NT PROBNP//NATRIURETIC PEPTIDES |
9 | 0.0000075409 | ISCHEMIC HEPATITIS//HYPOXIC HEPATITIS//SHOCK LIVER |
10 | 0.0000066770 | FLOSEQUINAN//BTS 53 554//FIRST DOSE HYPOTENSION |